Towards an improved serogroup B Neisseria meningitidis vaccine.
Meningococcal disease, presenting primarily as septicaemia and meningitis, continues to be a devastating problem around the world. Over the last century, vaccine development has been undertaken in earnest for the prevention of this disease. Polysaccharide vaccines have been available for almost 40 y...
Main Authors: | Perrett, K, Pollard, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2005
|
Similar Items
-
A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty.
by: Andrews, S, et al.
Published: (2014) -
A vaccine against serogroup B Neisseria meningitidis: Dealing with uncertainty
by: Andrews, S, et al.
Published: (2014) -
Correction: Molecular Epidemiology of Neisseria meningitidis Serogroup B in Brazil
Published: (2012-01-01) -
Serogroup A Neisseria meningitidis with Reduced Susceptibility to Ciprofloxacin
by: Jacob Strahilevitz, et al.
Published: (2008-10-01) -
Neisseria meningitidis serogroup X sequence type 767 in Turkey.
by: Kiliç, A, et al.
Published: (2010)